Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00440388
Status:
COMPLETED
Last Update Posted:
2010-08-27
First Post:
2007-02-23
Brief Title:
Safety Efficacy Study of AT-101 in Combination w Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkins Lymphoma
Sponsor:
Ascenta Therapeutics
Organization:
Ascenta Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10
Start Date Type:
None
Primary Completion Date:
2008-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-11
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-23
First Submit QC Date:
February 26 2007
Study First Post Date:
2007-02-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2010-08-12
Disp First Submit QC Date:
August 12 2010
Disp First Post Date:
2010-08-17
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2010-08-24
Last Update Post Date:
2010-08-27
Last Update Post Date Type:
ESTIMATED